SEC Form D · filed September 13, 2016
Checkpoint Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
David J. Horin · New York, NYExecLindsay A. Rosenwald · New York, NYDirectorMichael S. Weiss · New York, NYDirectorNeil A. Herskowitz · New York, NYDirectorJames F. Oliviero, Iii · New York, NYExecScott A. Boilen · New York, NYDirectorBarry A. Salzman · New York, NYDirectorStuart Ellman · New York, NYExecChristopher J. Grasso · Hamilton, BermudaDirectorJeffrey Dachis · New York, NYDirectorSteve Traxler · Chicago, ILDirectorJohn S. Struck · Hamilton, BermudaDirectorOlaf Carlson-Wee · Danville, CAExecEthan Kay · Irvine, CADirectorNeil Catania · COCONUT CREEK, FLDirectorJames F. Oliviero, Iii · New York, NYExecScott A. Boilen · New York, NYDirectorBarry A. Salzman · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗